Xihan Wu

1.3k total citations
35 papers, 1.1k citations indexed

About

Xihan Wu is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Xihan Wu has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 11 papers in Organic Chemistry and 10 papers in Oncology. Recurrent topics in Xihan Wu's work include Chemical Synthesis and Analysis (8 papers), Bone health and treatments (7 papers) and Estrogen and related hormone effects (5 papers). Xihan Wu is often cited by papers focused on Chemical Synthesis and Analysis (8 papers), Bone health and treatments (7 papers) and Estrogen and related hormone effects (5 papers). Xihan Wu collaborates with scholars based in China and United States. Xihan Wu's co-authors include Shaomeng Wang, Min Ji, Ramzi M. Mohammad, Yuyuan Xie, Beth Levant, Jianyong Chen, Yan Ling, Ayad Al‐Katib, Amro Aboukameel and Ben Chen and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Xihan Wu

34 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xihan Wu China 16 781 275 249 119 109 35 1.1k
Nigel J. Liverton United States 24 726 0.9× 711 2.6× 201 0.8× 55 0.5× 99 0.9× 61 1.8k
Aude Echalier United Kingdom 21 729 0.9× 245 0.9× 377 1.5× 51 0.4× 124 1.1× 29 1.3k
Sang Min Lim South Korea 19 948 1.2× 385 1.4× 281 1.1× 25 0.2× 90 0.8× 50 1.5k
David M. Ryckman United States 18 1.3k 1.7× 423 1.5× 413 1.7× 42 0.4× 82 0.8× 31 1.8k
Ribo Guo United States 14 904 1.2× 193 0.7× 261 1.0× 119 1.0× 78 0.7× 18 1.2k
Marc O’Reilly United Kingdom 15 1.0k 1.3× 137 0.5× 219 0.9× 46 0.4× 158 1.4× 20 1.3k
Butrus Atrash United Kingdom 18 767 1.0× 260 0.9× 323 1.3× 21 0.2× 114 1.0× 39 1.2k
Urs Regenass Switzerland 23 860 1.1× 194 0.7× 315 1.3× 47 0.4× 26 0.2× 43 1.3k
Jaroslav Veselý Czechia 8 674 0.9× 196 0.7× 524 2.1× 71 0.6× 64 0.6× 17 1.1k
S. J. DESOLMS United States 23 1.5k 1.9× 627 2.3× 752 3.0× 109 0.9× 76 0.7× 39 2.2k

Countries citing papers authored by Xihan Wu

Since Specialization
Citations

This map shows the geographic impact of Xihan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xihan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xihan Wu more than expected).

Fields of papers citing papers by Xihan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xihan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xihan Wu. The network helps show where Xihan Wu may publish in the future.

Co-authorship network of co-authors of Xihan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xihan Wu. A scholar is included among the top collaborators of Xihan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xihan Wu. Xihan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qin, Tian, et al.. (2022). Low Power Consumption Hybrid-Integrated Thermo-Optic Switch with Polymer Cladding and Silica Waveguide Core. Polymers. 14(23). 5234–5234. 6 indexed citations
2.
Liu, Wang, Yucheng Lu, Xiao Liu, et al.. (2016). Antitumor activity of TY-011 against gastric cancer by inhibiting Aurora A, Aurora B and VEGFR2 kinases. Journal of Experimental & Clinical Cancer Research. 35(1). 183–183. 15 indexed citations
4.
Zhang, Manchao, Yan Ling, Chao‐Yie Yang, et al.. (2007). A novel Bcl-2 small molecule inhibitor 4-(3-methoxy-phenylsulfannyl)-7-nitro-benzofurazan-3-oxide (MNB)-induced apoptosis in leukemia cells. Annals of Hematology. 86(7). 471–481. 11 indexed citations
5.
Wang, Junbo, et al.. (2006). Synthesis of novel bone-targeted agents for treatment of osteoporosis. Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry. 45(1). 318–321. 1 indexed citations
6.
Liu, Bo, Chunhao Yang, Guangyu Xu, et al.. (2005). Syntheses of quinolone hydrochloride enantiomers from synthons (R)- and (S)-2-methylpiperazine. Bioorganic & Medicinal Chemistry. 13(7). 2451–2458. 5 indexed citations
7.
Ji, Min, Jianyong Chen, Ke Ding, et al.. (2005). Design, synthesis and structure–activity relationship studies of hexahydropyrazinoquinolines as a novel class of potent and selective dopamine receptor 3 (D3) ligands. Bioorganic & Medicinal Chemistry Letters. 15(6). 1701–1705. 20 indexed citations
8.
Wang, Junbo, Chunhao Yang, Xueming Yan, Xihan Wu, & Yuyuan Xie. (2005). Novel Bone-targeted Agents for Treatment of Osteoporosis. Chinese Chemical Letters. 16(7). 859–862. 5 indexed citations
9.
Ding, Hua‐Sheng, Chao Zhang, Xihan Wu, et al.. (2005). Novel indole α-methylene-γ-lactones as potent inhibitors for AKT-mTOR signaling pathway kinases. Bioorganic & Medicinal Chemistry Letters. 15(21). 4799–4802. 15 indexed citations
10.
Mohammad, Ramzi M., Shaomeng Wang, Sanjeev Banerjee, et al.. (2005). Nonpeptidic Small-Molecule Inhibitor of Bcl-2 and Bcl-XL, (???)-Gossypol, Enhances Biological Effect of Genistein Against BxPC-3 Human Pancreatic Cancer Cell Line. Pancreas. 31(4). 317–324. 57 indexed citations
11.
Ji, Qinggang, Jie Gao, Junbo Wang, et al.. (2005). Benzothieno[3,2‐b]indole Derivatives as Potent Selective Estrogen Receptor Modulators.. ChemInform. 36(40). 1 indexed citations
12.
Yang, Chunhao, Guangyu Xu, Jia Li, et al.. (2005). Benzothiophenes containing a piperazine side chain as selective ligands for the estrogen receptor α and their bioactivities in vivo. Bioorganic & Medicinal Chemistry Letters. 15(5). 1505–1507. 23 indexed citations
13.
Ji, Qinggang, Jie Gao, Junbo Wang, et al.. (2005). Benzothieno[3,2-b]indole derivatives as potent selective estrogen receptor modulators. Bioorganic & Medicinal Chemistry Letters. 15(11). 2891–2893. 28 indexed citations
14.
Wu, Xihan, et al.. (2004). Design, synthesis, and evaluation of hexahydrobenz[f]isoquinolines as a novel class of dopamine 3 receptor ligands. Bioorganic & Medicinal Chemistry Letters. 14(23). 5813–5816. 7 indexed citations
15.
Ma, Ji, et al.. (2004). DNA topoisomerase I inhibitors from Rinorea anguifera. Bioorganic & Medicinal Chemistry Letters. 15(3). 813–816. 16 indexed citations
16.
Xu, Guangyu, Chunhao Yang, Bo Liu, Xihan Wu, & Yuyuan Xie. (2004). Synthesis of New Potential Chelating Agents: Catechol—Bisphosphonate Conjugates for Metal Intoxication Therapy.. ChemInform. 35(34).
17.
Xu, Guangyu, Yuyuan Xie, & Xihan Wu. (2004). A FACILE AND DIRECT SYNTHESIS OF ALENDRONATE FROM PYRROLIDONE. Organic Preparations and Procedures International. 36(2). 185–187. 6 indexed citations
19.
Enyedy, Istvan, Yan Ling, Kassoum Nacro, et al.. (2001). Discovery of Small-Molecule Inhibitors of Bcl-2 through Structure-Based Computer Screening. Journal of Medicinal Chemistry. 44(25). 4313–4324. 243 indexed citations
20.
Wu, Xihan, Liang Xu, & Junchao Cai. (1999). Asymmetric synthesis and antitumor activity of cycloalkanin. Bioorganic & Medicinal Chemistry Letters. 9(18). 2635–2638. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026